Coherus Oncology, Inc.

CHRS· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$1.44+2.13%

2026-08-03

Financials

Valuation Metrics

Coherus Oncology, Inc.'s Market Cap is $222M. At end of 2025 it was $171M. Ranked #3020 of 3,112 in US market (top 97%), #1369 of 1,445 on NASDAQ (top 95%), #252 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 94%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$222M	US#3,020/3,112 Sec#252/269
Revenue	$47M	US#2,865/3,112 Sec#158/269
Net Income	$-152M	US—/3,112 Sec—/269
Total Assets	$266M	US#2,929/3,112 Sec#227/269
Net Assets	$79M	US#2,903/3,112 Sec#234/269
Value
P/B	2.83x	US#1,603/3,112 Sec#81/269
P/S	4.74x	US#2,222/3,112 Sec#74/269
FCF Yield	-76.79%	US—/3,112 Sec—/269
Profitability
ROE	-192.90%	US#2,912/3,112 Sec#237/269
ROA	-57.01%	US#2,989/3,112 Sec#232/269
Op. Margin	-362.07%	US#2,887/3,112 Sec#158/269
Revenue Growth	61.99%	US#242/3,112 Sec#47/269
Earnings Growth	-697.37%	US#2,346/3,112 Sec#91/269
Financial Health
Debt Ratio	238.35%	US#1,942/3,112 Sec#208/269
Total Debt	$54M	US#2,519/3,112 Sec#144/269
FCF	$-171M	US#2,702/3,112 Sec#201/269
Cash	$115M	US#2,132/3,112 Sec#165/269
Current Ratio	1.56x	US#1,604/3,112 Sec#242/269
Performance
1Y Return	64.05%	US#529/3,112 Sec#104/269
1M Return	-0.69%	US#1,749/3,112 Sec#85/269
From 52W High	-45.04%	US#2,670/3,112 Sec#207/269
1Y MDD	-45.82%	US#2,233/3,112 Sec#171/269
Trading
Volume	465,656 shares	US#2,125/3,112 Sec#207/269
Trading Value	$670544.00	US#3,061/3,112 Sec#263/269
Per Share
EPS	$-1.41	US—/3,112 Sec—/269
BPS	$0.51	US#2,679/3,112 Sec#219/269